Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/2127
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKavanaugh, A-
dc.contributor.authorAntoni, C.E.-
dc.contributor.authorKrueger, GG-
dc.contributor.authorGladman, D-
dc.contributor.authorBirbara, C-
dc.contributor.authorBoling, EP-
dc.contributor.authorSiegel, EL-
dc.contributor.authorHalter, DG-
dc.contributor.authorde Vlam, K-
dc.contributor.authorKirkham, B-
dc.contributor.authorBeutler, A-
dc.contributor.authorGuzzo, C-
dc.contributor.authorZhou, B-
dc.contributor.authorDooley, LT-
dc.contributor.authorMease, Philip J.-
dc.contributor.authorGEUSENS, Piet-
dc.date.accessioned2007-11-11T20:38:43Z-
dc.date.available2007-11-11T20:38:43Z-
dc.date.issued2005-
dc.identifier.citationARTHRITIS AND RHEUMATISM, 52(9). p. S210-S210-
dc.identifier.issn0004-3591-
dc.identifier.urihttp://hdl.handle.net/1942/2127-
dc.languageEnglish-
dc.language.isoen-
dc.publisherWILEY-LISS-
dc.titleImprovement in-clinical measures of psoriatic arthritis in infliximab-treated patients: 1 year results from IMPACT 2.-
dc.typeJournal Contribution-
dc.identifier.epageS210-
dc.identifier.issue9-
dc.identifier.spageS210-
dc.identifier.volume52-
local.format.pages1-
local.bibliographicCitation.jcatM-
dc.description.notesUniv Calif San Diego, La Jolla, CA 92093 USA. Univ Erlangen Nurnberg, Erlangen, Germany. Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA. Toronto Western Hosp, Toronto, ON M5T 2S8, Canada. Univ Massachusetts, Sch Med, Worcester, MA 01605 USA. Rheumatol & Osteoporosis Ctr, Upland, CA USA. Ctr Rheumatol & Bone Res, Wheaton, MD USA. Inst Clin Res, Houston, TX USA. Univ Ctr, Diepenbeek, Belgium. Univ Hosp, Maastricht, Netherlands. Katholieke Univ Leuven Hosp, B-3000 Louvain, Belgium. Guys Hosp, Dept Rheumatol, London SE1 9RT, England. Centocor Inc, Malvern, PA 19355 USA. Swedish Med Ctr, Seattle, WA USA.-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.bibliographicCitation.oldjcatA5-
dc.identifier.isi000232207801015-
item.fullcitationKavanaugh, A; Antoni, C.E.; Krueger, GG; Gladman, D; Birbara, C; Boling, EP; Siegel, EL; Halter, DG; de Vlam, K; Kirkham, B; Beutler, A; Guzzo, C; Zhou, B; Dooley, LT; Mease, Philip J. & GEUSENS, Piet (2005) Improvement in-clinical measures of psoriatic arthritis in infliximab-treated patients: 1 year results from IMPACT 2.. In: ARTHRITIS AND RHEUMATISM, 52(9). p. S210-S210.-
item.fulltextWith Fulltext-
item.contributorKavanaugh, A-
item.contributorAntoni, C.E.-
item.contributorKrueger, GG-
item.contributorGladman, D-
item.contributorBirbara, C-
item.contributorBoling, EP-
item.contributorSiegel, EL-
item.contributorHalter, DG-
item.contributorde Vlam, K-
item.contributorKirkham, B-
item.contributorBeutler, A-
item.contributorGuzzo, C-
item.contributorZhou, B-
item.contributorDooley, LT-
item.contributorMease, Philip J.-
item.contributorGEUSENS, Piet-
item.accessRightsRestricted Access-
crisitem.journal.issn0004-3591-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
486203928a2953b8cb30952db4453cc8.pdf
  Restricted Access		503.58 kBAdobe PDFView/Open    Request a copy
Show simple item record

Page view(s)

20
checked on Nov 7, 2023

Download(s)

6
checked on Nov 7, 2023

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.